CN105683209B - 2’-脱氧-2’,2’-二氟四氢尿苷的合成途径 - Google Patents
2’-脱氧-2’,2’-二氟四氢尿苷的合成途径 Download PDFInfo
- Publication number
- CN105683209B CN105683209B CN201480059455.9A CN201480059455A CN105683209B CN 105683209 B CN105683209 B CN 105683209B CN 201480059455 A CN201480059455 A CN 201480059455A CN 105683209 B CN105683209 B CN 105683209B
- Authority
- CN
- China
- Prior art keywords
- compound
- salt
- catalyst
- acid
- dbu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0201—Oxygen-containing compounds
- B01J31/0209—Esters of carboxylic or carbonic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0237—Amines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0244—Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361896703P | 2013-10-29 | 2013-10-29 | |
| US61/896703 | 2013-10-29 | ||
| PCT/US2014/062874 WO2015066162A1 (en) | 2013-10-29 | 2014-10-29 | Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105683209A CN105683209A (zh) | 2016-06-15 |
| CN105683209B true CN105683209B (zh) | 2019-03-08 |
Family
ID=51982743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480059455.9A Active CN105683209B (zh) | 2013-10-29 | 2014-10-29 | 2’-脱氧-2’,2’-二氟四氢尿苷的合成途径 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US9834576B2 (enExample) |
| EP (1) | EP3063164B1 (enExample) |
| JP (1) | JP6427567B2 (enExample) |
| KR (1) | KR102272773B1 (enExample) |
| CN (1) | CN105683209B (enExample) |
| AU (1) | AU2014342402B2 (enExample) |
| BR (1) | BR112016008855B1 (enExample) |
| CA (1) | CA2926734C (enExample) |
| ES (1) | ES2712877T3 (enExample) |
| IL (1) | IL244849B (enExample) |
| MX (1) | MX363205B (enExample) |
| MY (1) | MY176465A (enExample) |
| NZ (1) | NZ718607A (enExample) |
| PH (1) | PH12016500683B1 (enExample) |
| RU (1) | RU2681939C2 (enExample) |
| SA (1) | SA516371019B1 (enExample) |
| SG (1) | SG11201602614XA (enExample) |
| WO (1) | WO2015066162A1 (enExample) |
| ZA (1) | ZA201602315B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2926734C (en) | 2013-10-29 | 2022-03-15 | Otsuka Pharmaceutical Co., Ltd. | Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines |
| US11224610B2 (en) | 2018-09-19 | 2022-01-18 | Otsuka Pharmaceutical Co., Ltd. | Low dose combination CDA substrate drug/cedazuridine with extended administration |
| EP4041743A4 (en) * | 2019-10-08 | 2024-03-13 | Otsuka Pharmaceutical Co., Ltd. | HIGH PURITY 2'-DEOXY-2',2'-DIFLUORTETRAHYDROURIDINE AND METHOD FOR THE PRODUCTION THEREOF |
| PT4069254T (pt) | 2020-02-25 | 2024-10-10 | Otsuka Pharma Co Ltd | Formas sólidas de dosagem oral compreendendo decitabina e cedazuridina |
| KR20230043904A (ko) | 2020-07-24 | 2023-03-31 | 엘랑코 유에스 인코포레이티드 | 이속사졸린 화합물 및 이의 중간체의 제조 공정 |
| CN113402573B (zh) * | 2020-07-31 | 2023-06-20 | 集美大学 | 一种鞣质类化合物及其提取方法和应用 |
| US20240279266A1 (en) * | 2021-05-29 | 2024-08-22 | Msn Laboratories Private Limited, R&D Center | An improved process for the preparation of (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-4-hydroxy-1,3-diazinan-2one and its intermediate compounds |
| TWI821074B (zh) * | 2021-12-25 | 2023-11-01 | 台灣神隆股份有限公司 | 製備希達路里定（cedazuridine）的方法 |
| US20230271996A1 (en) * | 2021-12-25 | 2023-08-31 | Scinopharm Taiwan, Ltd. | Process for preparing cedazuridine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101827856A (zh) * | 2007-10-16 | 2010-09-08 | 卫才公司 | 作为胞嘧啶核苷脱氨酶抑制剂的2′-氟-2′-脱氧四氢尿苷 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526988A (en) | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
| US4965374A (en) | 1987-08-28 | 1990-10-23 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
| US5223608A (en) | 1987-08-28 | 1993-06-29 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
| FR2682112B1 (fr) | 1991-10-08 | 1993-12-10 | Commissariat A Energie Atomique | Procede de synthese d'acide ribonucleique (arn) utilisant un nouveau reactif de deprotection. |
| US5371210A (en) | 1992-06-22 | 1994-12-06 | Eli Lilly And Company | Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| US5521294A (en) | 1995-01-18 | 1996-05-28 | Eli Lilly And Company | 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides |
| US6001994A (en) | 1995-12-13 | 1999-12-14 | Eli Lilly And Company | Process for making gemcitabine hydrochloride |
| EP0876149A4 (en) | 1995-12-22 | 2001-09-26 | Univ East Carolina | METHOD FOR TREATING DISORDERS CHARACTERIZED BY A CYTIDINE DEAMINASE OR DESOXYCYTIDINE DEAMINASE |
| US5760208A (en) | 1996-08-14 | 1998-06-02 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Process to prepare pyrimidine nucleosides |
| CN102241720B (zh) | 2000-11-29 | 2014-01-29 | 三井化学株式会社 | L-核酸衍生物及其合成方法 |
| FI112640B (fi) | 2000-12-22 | 2003-12-31 | Kone Corp | Hissin turvalaite |
| KR101108407B1 (ko) * | 2006-06-21 | 2012-01-30 | 일라이 릴리 앤드 캄파니 | 젬시타빈 아미드 전구약물의 결정 형태, 그의 조성물 및 용도 |
| CA2926734C (en) | 2013-10-29 | 2022-03-15 | Otsuka Pharmaceutical Co., Ltd. | Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines |
-
2014
- 2014-10-29 CA CA2926734A patent/CA2926734C/en active Active
- 2014-10-29 JP JP2016526889A patent/JP6427567B2/ja active Active
- 2014-10-29 CN CN201480059455.9A patent/CN105683209B/zh active Active
- 2014-10-29 SG SG11201602614XA patent/SG11201602614XA/en unknown
- 2014-10-29 EP EP14802970.5A patent/EP3063164B1/en active Active
- 2014-10-29 KR KR1020167014187A patent/KR102272773B1/ko active Active
- 2014-10-29 WO PCT/US2014/062874 patent/WO2015066162A1/en not_active Ceased
- 2014-10-29 MY MYPI2016701546A patent/MY176465A/en unknown
- 2014-10-29 US US15/027,022 patent/US9834576B2/en active Active
- 2014-10-29 ES ES14802970T patent/ES2712877T3/es active Active
- 2014-10-29 BR BR112016008855-7A patent/BR112016008855B1/pt active IP Right Grant
- 2014-10-29 AU AU2014342402A patent/AU2014342402B2/en active Active
- 2014-10-29 RU RU2016115523A patent/RU2681939C2/ru active
- 2014-10-29 NZ NZ71860714A patent/NZ718607A/en unknown
- 2014-10-29 MX MX2016005596A patent/MX363205B/es unknown
-
2016
- 2016-03-31 IL IL24484916A patent/IL244849B/en active IP Right Grant
- 2016-04-06 ZA ZA2016/02315A patent/ZA201602315B/en unknown
- 2016-04-13 PH PH12016500683A patent/PH12016500683B1/en unknown
- 2016-04-27 SA SA516371019A patent/SA516371019B1/ar unknown
-
2017
- 2017-11-15 US US15/813,743 patent/US10526362B2/en active Active
-
2019
- 2019-12-17 US US16/717,811 patent/US11028119B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101827856A (zh) * | 2007-10-16 | 2010-09-08 | 卫才公司 | 作为胞嘧啶核苷脱氨酶抑制剂的2′-氟-2′-脱氧四氢尿苷 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105683209B (zh) | 2’-脱氧-2’,2’-二氟四氢尿苷的合成途径 | |
| JP6731477B2 (ja) | ヌクレオシドホスホルアミダート系プロドラッグの製造方法及びその中間体 | |
| JP7347852B2 (ja) | 重水素化大環状化合物の調製方法 | |
| CA2882119A1 (en) | Solid forms of an antiviral compound | |
| CN107530349B (zh) | 作为a2b拮抗剂的黄嘌呤取代的炔基氨基甲酸酯/反式氨基甲酸酯 | |
| CN101875680A (zh) | 一种核苷类化合物及其制备方法和应用 | |
| CN104530068B (zh) | 用于制备异法戈明的化合物 | |
| WO2008157658A1 (en) | Deuterium-enriched montelukast | |
| EP3360858B1 (en) | Process for producing an aminopyrrolidine derivative | |
| CN113444083B (zh) | 一种小分子酪氨酸激酶抑制剂的制备方法 | |
| KR20220011671A (ko) | 소프피로늄 브롬화물 결정체 및 그의 제조방법 | |
| CN112430208A (zh) | 一种pf-06651600中间体的制备方法 | |
| CN101805339B (zh) | 一种制备恩替卡韦化合物的方法 | |
| CN113912567A (zh) | 吡喃葡萄糖基衍生物的制备方法及其中间体 | |
| CN101880285B (zh) | 一种烯丙基取代喜树碱化合物的合成方法 | |
| CA3158942A1 (en) | Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
| KR100741310B1 (ko) | 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법 | |
| CN103755624A (zh) | 一种哌啶衍生物的合成方法 | |
| HK1256344B (en) | Process for producing an aminopyrrolidine derivative | |
| CN106117290A (zh) | 一种抗癌药物地西他滨的制备方法 | |
| HK1223627B (en) | Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines | |
| JP2010053068A (ja) | Ｎ−（４−ヨードフェニル）−ｎ−メチルピリミジン−２−アミンの製造方法 | |
| CN101654432A (zh) | 2-吡啶酮的一种n-烷基化方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250827 Address after: Tokyo, Japan Patentee after: TAIHO PHARMACEUTICAL Co.,Ltd. Country or region after: Japan Address before: Japan Tokyo Chiyoda Kanda Cho Division 2 chome 9 GA Patentee before: OTSUKA PHARMACEUTICAL Co.,Ltd. Country or region before: Japan |
|
| TR01 | Transfer of patent right |